Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical

José González-Martínez1, Andrzej W Cwetsch1,2,3, Diego Martínez-Alonso1

  • 1Cell Division and Cancer group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

JCI Insight
|July 8, 2021
PubMed

Insights

Congenital microcephaly (MCPH) can stem from centriole defects in neural progenitors. Loss of CEP135 causes instability and cell death, leading to brain malformations if cells aren't cleared.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Congenital microcephaly (MCPH) is a neurodevelopmental disorder linked to gene mutations affecting mitosis.
  • The precise cellular mechanisms driving MCPH remain unclear due to genetic diversity and limited in vivo research.

Purpose of the Study:

  • To investigate the cellular pathogenesis of MCPH by comparing the effects of different gene knockouts in vivo.
  • To elucidate the role of centriole integrity in neural progenitor cells during brain development.

Main Methods:

  • CRISPR/Cas9 gene editing to create knockout models for key MCPH-associated genes (ASPM, CDK5RAP2, CEP135).
  • Development of a mouse model for MCPH8 (CEP135 deficiency).
  • Analysis of neural progenitor cell dynamics, chromosome segregation, TP53 activation, and cell death.

Main Results:

  • Defects in spindle pole proteins (ASPM) caused mild MCPH.
  • Loss of centrosome (CDK5RAP2) or centriole (CEP135) regulators led to delayed chromosome segregation and instability in neural progenitors.
  • CEP135 deficiency resulted in centriole duplication defects, TP53 activation, and neural progenitor cell death.
  • Trp53 ablation in Cep135-deficient mice prevented cell death but not microcephaly, causing subcortical heterotopias.

Conclusions:

  • Centriole defects in neural progenitors contribute to MCPH pathogenesis.
  • Failure to eliminate chromosomally unstable cells due to centriole dysfunction can lead to brain architectural defects.
  • TP53-mediated cell death is a critical mechanism for clearing defective cells, but its absence does not prevent microcephaly itself.